| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Director | President &COO +3 more
4 companies
Gala Renee D serves as a SVP, Chief Financial Officer at TBPH and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 4 buys and 8 sells. Those positions are worth an estimated $37.5M at current prices.
The biggest single holding is JAZZ (~$33.4M) as President &CEO. The recent filings there lean toward selling, a net 12,635 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | JAZZ Jazz Pharmaceuticals Plc | President &CEO | Sell | 2,000 | $236.40 | $472,800.00 | -1.4% | - | - | |
| Sep 8, 2026 | JAZZ Jazz Pharmaceuticals Plc | President &CEO | Sell | 2,000 | $243.03 | $486,060.00 | -1.4% | - | - | |
| May 18, 2023 | JAZZ Jazz Pharmaceuticals Plc | EVP &Chief Financial Officer | Sell | 6,000 | $131.75 | $790,474.20 | -14.3% | +4.8% | -17.3% | |
| Dec 21, 2022 | JAZZ Jazz Pharmaceuticals Plc | EVP &Chief Financial Officer | Sell | 2,635 | $160.00 | $421,600.00 | -7.5% | -11.8% | -23.6% | |
| Aug 15, 2018 | TBPH Theravance Biopharma, Inc. | SVP, Chief Financial Officer | Sell | 43,743 | $26.79 | $1,171,791.02 | -20.4% | - | - | |
| May 18, 2018 | TBPH Theravance Biopharma, Inc. | SVP, Chief Financial Officer | Sell | 10,000 | $24.29 | $242,877.00 | -4.1% | - | - | |
| Mar 7, 2018 | CORT Corcept Therapeutics Inc | Director | Buy | 10,000 | $15.51 | $155,101.50 | New | - | - | |
| Aug 17, 2015 | TBPH Theravance Biopharma, Inc. | SVP, Chief Financial Officer | Buy | 10,000 | $12.18 | $121,750.00 | +6.6% | - | - |